Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 798

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 6
Chunk 798
---
which is the amount of interest credited to the Debenture Holders over the actual interest earned of $2,444.
The value of the warrants and additional shares issued of $509,310
is reflected in the Consolidated Statements of Changes In Stockholders’ Equity.

    F-18

On
February 5, 2024, an investor in our Company became a greater than 10% shareholder of the Company converted an
outstanding promissory note dated October 16, 2023, as amended on November 13, 2023 (the “Convertible Note”), in the
amount of $120,000,
plus accrued interest of $3,255
into 164,340
shares of the Company’s common stock. The maturity date of the Convertible Note was May
14, 2024, the interest rate was 10%
per annum and the effective conversion price was $0.75
per share.

Sale
of Common Stock

On
August 4, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with two accredited investors
(the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a registered direct offering
(the “Registered Offering”) 1,200,002 shares (“Registered Shares”) of the Company’s common stock (the “Common
Stock”) at a price of $1.50 per share. Under the Purchase Agreements, the Company also agreed to issue and sell to the Investors
in a concurrent private placement (the “Private Placement,” and together with the Registered Offering, the “Offering”)
warrants to purchase an aggregate of 1,200,002 shares of Common Stock (the “Warrants”). Net proceeds from the Registered
Offering were $1,775,782, after deducting offering expenses of $24,218. The net proceeds were allocated between the common stock and
warrants based on the relative fair values which were $502,417 and $1,273,365, respectively. The Warrants are exercisable any time on
or after February 5, 2024 and prior to August 10, 2026 at an exercise price of $2.00 per share.

On
December 6, 2023, the Company entered into a Private Offering (the “Purchase Agreement”) with five accredited investors (the
“Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a direct offering